About Culture Biosciences
Culture Biosciences is a company based in San Francisco (United States) founded in 2016.. Culture Biosciences has raised $107.22 million across 6 funding rounds from investors including Verily, TPB and Synthesis Capital. The company has 35 employees as of December 31, 2020. Culture Biosciences offers products and services including Stratyx™, Console, and Nexxys™. Culture Biosciences operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Headquarter San Francisco, United States
- Employees 35 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Culture Biosciences, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$107.22 M (USD)
in 6 rounds
-
Latest Funding Round
-
Investors
Verily
& 13 more
-
Employee Count
35
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Culture Biosciences
Culture Biosciences offers a comprehensive portfolio of products and services, including Stratyx™, Console, and Nexxys™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Cloud-integrated mobile bioreactor for cell culture process development.
Cloud-based system for bioprocess management and data analytics.
Lab-based system for bioprocess experiments and optimization.
Unlock access to complete
Funding Insights of Culture Biosciences
Culture Biosciences has successfully raised a total of $107.22M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
-
First Round
First Round
(01 Jun 2018)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2025 | Amount | Series C - Culture Biosciences | Valuation |
investors |
|
| Oct, 2021 | Amount | Series B - Culture Biosciences | Valuation | Northpond Ventures | |
| Mar, 2020 | Amount | Series A - Culture Biosciences | Valuation | Cultivian Sandbox |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Culture Biosciences
Culture Biosciences has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include Verily, TPB and Synthesis Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on SaaS and consumer sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Culture Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Culture Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Culture Biosciences Comparisons
Competitors of Culture Biosciences
Culture Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Culture Biosciences
Frequently Asked Questions about Culture Biosciences
When was Culture Biosciences founded?
Culture Biosciences was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Where is Culture Biosciences located?
Culture Biosciences is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Culture Biosciences?
Chris Williams is the current CEO of Culture Biosciences.
Is Culture Biosciences a funded company?
Culture Biosciences is a funded company, having raised a total of $107.22M across 6 funding rounds to date. The company's 1st funding round was a Series A of $21.6M, raised on Jun 01, 2018.
How many employees does Culture Biosciences have?
As of Dec 31, 2020, the latest employee count at Culture Biosciences is 35.
What does Culture Biosciences do?
Culture Biosciences was founded in 2016 in San Francisco, United States, and operates in the biomanufacturing sector. A digital platform has been developed by the company, integrating automated bioreactors, robotic sample handling, and cloud-based data monitoring. Services offered include strain screening, media optimization, and process development to support research activities.
Who are the top competitors of Culture Biosciences?
Culture Biosciences's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Culture Biosciences offer?
Culture Biosciences offers Stratyx™, Console, and Nexxys™.
Who are Culture Biosciences's investors?
Culture Biosciences has 14 investors. Key investors include Verily, TPB, Synthesis Capital, Cultivian Sandbox, and Craft Ventures.